CatSci are pleased to share that we will be attending the Biotech Outsourcing Strategies (BOS) Event in Basel, Switzerland. Held at the Congress Centre Basel, the BOS Event is a showcase of Pharmaceutical Discovery Outsourcing and Small Molecule CMC Outsourcing.
Several members of the CatSci team will be in attendance, including:
• Dr Robert Dennehy, Director of Material Sciences
• Jenn Clark, Head of Account Management
• Dr João Madeira do Ó – Head of Business Development in Europe
• Dr Sofia C. Papadouli, Senior Marketing Manager
The expert team are looking forward to discussing CatSci’s capabilities, and how we bring together chemists, analysts, data specialists, material scientists, formulators, and pharmacists to deliver your best-in-class therapeutics. Come along to find out more about CatSci’s offerings and why we are a successful innovation partner of choice for pharmaceutical companies across the globe.
We are also looking forward to telling you all about SmartPath, our innovative new digital tool that will risk assess your API, project, and formulation data and offer smart mitigation strategies. With the premium SmartPath feature, you will work alongside Dr Robert Dennehy to devise a tailored life-cycle plan of your API to meet your budget and project needs. So, you can focus on what matters most – delivering your asset to the next step, without surprises or delays. To find out more about SmartPath, be sure to ask us about it when you see us.
BOS is sure to be an insightful and engaging event, and we are thrilled to be networking and connecting with the industry, as well as exhibiting what CatSci can do for you. If you would like to arrange a meeting with the team in advance, please get in touch here.